» Authors » Paul Kwon

Paul Kwon

Explore the profile of Paul Kwon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 432
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vermeire S, Schreiber S, Rubin D, DHaens G, Reinisch W, Watanabe M, et al.
Lancet Gastroenterol Hepatol . 2024 Dec; 10(2):138-153. PMID: 39637881
Background: There is a need for efficacious therapies for patients with Crohn's disease that are better tolerated and more durable than available treatments. We aimed to evaluate the efficacy and...
2.
Pamplin J, Remondelli M, Thota D, Trapier J, Davis W, Fisher N, et al.
Mil Med . 2024 May; 190(1-2):27-32. PMID: 38743585
The potential impact of large-scale combat operations and multidomain operations against peer adversaries poses significant challenges to the Military Health System including large volumes of critically ill and injured casualties,...
3.
Sheng Q, DAlessio J, Menezes D, Karim C, Tang Y, Tam A, et al.
Mol Cancer Ther . 2021 Apr; 20(7):1270-1282. PMID: 33879555
The cell surface glycoprotein P-cadherin is highly expressed in a number of malignancies, including those arising in the epithelium of the bladder, breast, esophagus, lung, and upper aerodigestive system. PCA062...
4.
Kimel M, Zeidler C, Kwon P, Revicki D, Stander S
JAMA Dermatol . 2020 Sep; 156(12):1354-1358. PMID: 32936233
Importance: There is an unmet need for psychometrically sound instruments to measure pruritus associated with prurigo nodularis (PN). Objective: To evaluate the psychometric properties of the itch numeric rating scale...
5.
Scheuerle A, Kwon P, Joing M
Birth Defects Res . 2019 Nov; 112(1):118-121. PMID: 31746564
Object: The NT-04 clinical trial of investigational medication NT100 had a limited, though geographically diverse, study population. To enhance potential birth defect identification, photographic dysmorphology exam of infants was performed...
6.
Farlow J, Nozadze M, Mitaishvili N, Kotorashvili A, Kotoria N, Arobelidze K, et al.
J Glob Antimicrob Resist . 2019 Nov; 21:363-368. PMID: 31730823
Objectives: This study reports the draft genomes of four newly isolated multidrug-resistant (MDR) Acinetobacter baumannii (A. baumannii) isolates (0830, 0365, 4022, and 2846) from western Georgia to identify putative antimicrobial...
7.
Chiou A, Choi S, Barriga M, Dutt-Singkh Y, Solis D, Nazaroff J, et al.
J Am Acad Dermatol . 2019 Sep; 82(6):1415-1421. PMID: 31541747
Background: Chronic pruritus causes major morbidity in epidermolysis bullosa (EB). The substance P-neurokinin 1 receptor (SP-NK1) pathway is a promising target for treating EB-related pruritus. Objective: To evaluate the safety...
8.
Stander S, Spellman M, Kwon P, Yosipovitch G
Expert Opin Investig Drugs . 2019 Jul; 28(8):659-666. PMID: 31272246
: Pruritus is a common symptom associated with several potential underlying causes, including both dermatologic and systemic diseases; it can also occur without an identifiable cause. Current treatment options are...
9.
Stander S, Kwon P, Hirman J, Perlman A, Weisshaar E, Metz M, et al.
J Am Acad Dermatol . 2019 Mar; 80(5):1395-1402. PMID: 30894279
Background: Anecdotal evidence suggests that neurokinin 1 receptor antagonism reduces pruritus intensity in chronic pruritic conditions such as prurigo nodularis (PN). Objective: This study assessed safety and efficacy of the...
10.
Nierode G, Gopal S, Kwon P, Clark D, Schaffer D, Dordick J
Biotechnol Bioeng . 2018 Sep; 116(1):168-180. PMID: 30229860
Identification of conditions for guided and specific differentiation of human stem cell and progenitor cells is important for continued development and engineering of in vitro cell culture systems for use...